K051619

Substantially Equivalent

LIPOPROTEIN FOR MULTIPLE ANALYTES

Applicant: Bayer Healthcare, LLC
Product code: JIX
Advisory panel: Clinical Chemistry
Date received: 2005-06-17
Decision date: 2005-08-01
Decision: Substantially Equivalent
Clearance type: Abbreviated
Location: Tarrytown, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.